UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
HanAll releases test results for dry eye treatment in US
HanAll Biopharma said Monday it has presented phase 2 clinical trial result...
by Lee Han-soo
|
2018-10-29 16:08
라인
JW invests in Argonaut Therapeutics
JW Pharmaceutical said Monday that it has signed a strategic investment agr...
by Lee Han-soo
|
2018-10-29 11:16
라인
AbbVie unveils P2-b clinical trial results for ulcerative colitis treatment
AbbVie said Friday that it has produced positive results from U-ACHIEVE, an...
by Lee Han-soo
|
2018-10-26 17:44
라인
Pfizer’s generic business turn ‘disastrous’ amid cancer controversy
Multinational pharmaceutical giant Pfizer’s generic business in Korea is no...
by So Jae-hyeon
|
2018-10-26 17:14
라인
SCM Lifescience gets ₩5.5 billion investment from Malaysia
SCM Lifescience said Thursday that it has received a 5.5 billion won ($4.8 ...
by Lee Han-soo
|
2018-10-26 15:00
라인
Ministry OKs phase-3a clinical trial for new anti-diabetes drug
Novo Nordisk said it would conduct phase 3a clinical trial for Ozempic in K...
by Lee Hye-seon
|
2018-10-26 14:18
라인
Hugel posts ₩34.9 billion in Q3 sales
Hugel said Thursday that it recorded sales of 34.9 billion won ($30.6 milli...
by Lee Han-soo
|
2018-10-26 13:49
라인
Viromed unveils reaction principle of VM202
ViroMed said Thursday that it has published the bell-shaped drug dose respo...
by Lee Han-soo
|
2018-10-25 17:21
라인
Daewoong releases research results for 2 drug candidates in US
Daewoong Pharmaceutical said Thursday that it has presented the trial resul...
by Lee Han-soo
|
2018-10-25 16:30
라인
Boehringer, Lilly unveil clinical results for diabetes treatment
Boehringer Ingelheim and Eli Lilly have published a new analysis on EMPA-RE...
by Lee Han-soo
|
2018-10-25 15:08
라인
‘Handok encouraged unlicensed medical practice for pharmacists’
Pharmaceutical firm Handok allegedly encouraged pharmacists to carry out un...
by So Jae-hyeon
|
2018-10-25 15:06
라인
Ono Pharma Korea rebuked for late reporting of adverse events
The Ministry of Food and Drug Safety issued a warning to Ono Pharma Korea f...
by Lee Hye-seon
|
2018-10-25 13:55
라인
Novartis struggles to restore sales of Alzheimer’s drug Exelon
Novartis has failed to restore the sales of Exelon, a patch for the treatme...
by Nam Doo-hyun
|
2018-10-25 11:04
라인
Anti-Alzheimer drink has no efficacy: civic group
Medical experts are increasingly raising suspicions over whether Handok’s n...
by So Jae-hyeon
|
2018-10-24 15:22
라인
Ono Pharma, BMS release 4 clinical trial results at EU meeting
Ono Pharma Korea and Bristol-Myers Squibb Korea have presented four new cli...
by Lee Han-soo
|
2018-10-24 15:15
라인
Daewoong wins nod for phase-3 study on new antiulcer drug
Daewoong Pharmaceutical said it obtained regulatory approval to conduct a p...
by Lee Hye-seon
|
2018-10-24 15:15
라인
Anticoagulant Lixiana outpaces Eliquis in Q3 prescriptions
Daiichi Sankyo’s Lixiana (edoxaban), a latecomer in the non-vitamin K antag...
by Nam Doo-hyun
|
2018-10-23 16:10
라인
ST Pharm’s HIV treatment to get support from US institute
ST Pharm said Tuesday that the U.S.’s National Institutes of Health (NIH) h...
by Lee Han-soo
|
2018-10-23 15:29
라인
Sales of antidiabetic SGLT-2 inhibitors expand in Q3
Antidiabetic drugs using sodium-glucose cotransporter 2 (SGLT-2) inhibitor ...
by So Jae-hyeon
|
2018-10-23 14:26
라인
France approves clinical trial for Bukwang’s dyskinesia treatment
Bukwang Pharmaceutical said Monday that it has won the approval of the Fren...
by Lee Han-soo
|
2018-10-23 12:15
-
이전
61
62
63
64
65
66
67
68
69
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top